412 related articles for article (PubMed ID: 36252475)
1. Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table.
Ranjbar M; Rahimi A; Baghernejadan Z; Ghorbani A; Khorramdelazad H
Int Immunopharmacol; 2022 Dec; 113(Pt A):109325. PubMed ID: 36252475
[TBL] [Abstract][Full Text] [Related]
2. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
3. Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches.
Moadab F; Khorramdelazad H; Abbasifard M
Life Sci; 2021 Mar; 269():119034. PubMed ID: 33453247
[TBL] [Abstract][Full Text] [Related]
4. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
Maus UA; Wellmann S; Hampl C; Kuziel WA; Srivastava M; Mack M; Everhart MB; Blackwell TS; Christman JW; Schlöndorff D; Bohle RM; Seeger W; Lohmeyer J
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L350-8. PubMed ID: 15516494
[TBL] [Abstract][Full Text] [Related]
5. Decoding the role of the CCL2/CCR2 axis in Alzheimer's disease and innovating therapeutic approaches: Keeping All options open.
Arfaei R; Mikaeili N; Daj F; Boroumand A; Kheyri A; Yaraghi P; Shirzad Z; Keshavarz M; Hassanshahi G; Jafarzadeh A; Shahrokhi VM; Khorramdelazad H
Int Immunopharmacol; 2024 Jun; 135():112328. PubMed ID: 38796962
[TBL] [Abstract][Full Text] [Related]
6. Blockade of CCL2/CCR2 signaling pathway prevents inflammatory monocyte recruitment and attenuates OVA-Induced allergic asthma in mice.
Jiang S; Wang Q; Wang Y; Song X; Zhang Y
Immunol Lett; 2019 Oct; 214():30-36. PubMed ID: 31454522
[TBL] [Abstract][Full Text] [Related]
7. CCL3/CCR1 mediates CD14
Zhao X; Gu M; Xu X; Wen X; Yang G; Li L; Sheng P; Meng F
Osteoarthritis Cartilage; 2020 May; 28(5):613-625. PubMed ID: 32006659
[TBL] [Abstract][Full Text] [Related]
8. CCL2 Promotes Novel Coronavirus-Mediated Inflammatory Responses in Macrophages.
Ding F; Dai M; Kang X; Zhang X; Li L; Zhao L; Jiang P; Gao H; Yan H
Clin Invest Med; 2023 Sep; 46(3):E34-45. PubMed ID: 37769276
[TBL] [Abstract][Full Text] [Related]
9. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.
Ben-Yehuda H; Arad M; Peralta Ramos JM; Sharon E; Castellani G; Ferrera S; Cahalon L; Colaiuta SP; Salame TM; Schwartz M
Mol Neurodegener; 2021 Jun; 16(1):39. PubMed ID: 34172073
[TBL] [Abstract][Full Text] [Related]
10. Post-BMT lung injury occurs independently of the expression of CCL2 or its receptor, CCR2, on host cells.
Panoskaltsis-Mortari A; Hermanson JR; Taras E; Wangensteen OD; Charo IF; Rollins BJ; Blazar BR
Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L284-92. PubMed ID: 14527928
[TBL] [Abstract][Full Text] [Related]
11. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
Xiang J; Lu M; Shi M; Cheng X; Kwakwa KA; Davis JL; Su X; Bakewell SJ; Zhang Y; Fontana F; Xu Y; Veis DJ; DiPersio JF; Ratner L; Sanderson RD; Noseda A; Mollah S; Li J; Weilbaecher KN
J Virol; 2022 Apr; 96(7):e0005722. PubMed ID: 35319225
[TBL] [Abstract][Full Text] [Related]
12. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
[TBL] [Abstract][Full Text] [Related]
13. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
14. The role of HMGB1 in COVID-19-induced cytokine storm and its potential therapeutic targets: A review.
Wulandari S; Hartono ; Wibawa T
Immunology; 2023 Jun; 169(2):117-131. PubMed ID: 36571562
[TBL] [Abstract][Full Text] [Related]
15. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
16. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.
Mahad D; Callahan MK; Williams KA; Ubogu EE; Kivisäkk P; Tucky B; Kidd G; Kingsbury GA; Chang A; Fox RJ; Mack M; Sniderman MB; Ravid R; Staugaitis SM; Stins MF; Ransohoff RM
Brain; 2006 Jan; 129(Pt 1):212-23. PubMed ID: 16230319
[TBL] [Abstract][Full Text] [Related]
17. Gas6 Promotes Inflammatory (CCR2
Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
[TBL] [Abstract][Full Text] [Related]
18. Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro.
Wang G; Guan J; Li G; Wu F; Yang Q; Huang C; Shao J; Xu L; Guo Z; Zhou Q; Zhu H; Chen Z
Dis Markers; 2021; 2021():6803510. PubMed ID: 34603560
[TBL] [Abstract][Full Text] [Related]
19. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Fei L; Ren X; Yu H; Zhan Y
Front Immunol; 2021; 12():771210. PubMed ID: 34804061
[TBL] [Abstract][Full Text] [Related]
20. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases.
Zhu S; Liu M; Bennett S; Wang Z; Pfleger KDG; Xu J
J Cell Physiol; 2021 Oct; 236(10):7211-7222. PubMed ID: 33782965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
